614 related articles for article (PubMed ID: 27572398)
1. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
2. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
Takizawa N; Kimura T; Watanabe T; Shibasaki M
Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849
[TBL] [Abstract][Full Text] [Related]
3. Characterization of susceptibility variants of influenza virus grown in the presence of T-705.
Daikoku T; Yoshida Y; Okuda T; Shiraki K
J Pharmacol Sci; 2014; 126(3):281-4. PubMed ID: 25296868
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of resistance to favipiravir in influenza.
Goldhill DH; Te Velthuis AJW; Fletcher RA; Langat P; Zambon M; Lackenby A; Barclay WS
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11613-11618. PubMed ID: 30352857
[TBL] [Abstract][Full Text] [Related]
6. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection.
Enkhtaivan G; Muthuraman P; Kim DH
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233349
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.
Sangawa H; Komeno T; Nishikawa H; Yoshida A; Takahashi K; Nomura N; Furuta Y
Antimicrob Agents Chemother; 2013 Nov; 57(11):5202-8. PubMed ID: 23917318
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
Checkmahomed L; Padey B; Pizzorno A; Terrier O; Rosa-Calatrava M; Abed Y; Baz M; Boivin G
Viruses; 2020 Oct; 12(10):. PubMed ID: 33049959
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of T-705 against influenza virus.
Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
[TBL] [Abstract][Full Text] [Related]
11. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
[TBL] [Abstract][Full Text] [Related]
12. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.
Baranovich T; Wong SS; Armstrong J; Marjuki H; Webby RJ; Webster RG; Govorkova EA
J Virol; 2013 Apr; 87(7):3741-51. PubMed ID: 23325689
[TBL] [Abstract][Full Text] [Related]
13. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
14. A point mutation in the polymerase protein PB2 allows a reassortant H9N2 influenza isolate of wild-bird origin to replicate in human cells.
Hussein ITM; Ma EJ; Hill NJ; Meixell BW; Lindberg M; Albrecht RA; Bahl J; Runstadler JA
Infect Genet Evol; 2016 Jul; 41():279-288. PubMed ID: 27101787
[TBL] [Abstract][Full Text] [Related]
15. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
16. Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.
Jin Z; Tucker K; Lin X; Kao CC; Shaw K; Tan H; Symons J; Behera I; Rajwanshi VK; Dyatkina N; Wang G; Beigelman L; Deval J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7504-16. PubMed ID: 26392512
[TBL] [Abstract][Full Text] [Related]
17. Novel Polyanions Inhibiting Replication of Influenza Viruses.
Ciejka J; Milewska A; Wytrwal M; Wojarski J; Golda A; Ochman M; Nowakowska M; Szczubialka K; Pyrc K
Antimicrob Agents Chemother; 2016 Apr; 60(4):1955-66. PubMed ID: 26729490
[TBL] [Abstract][Full Text] [Related]
18. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
[TBL] [Abstract][Full Text] [Related]
19. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
Rahman M; Hoque SA; Islam MA; Rahman SR
Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
